Who We Are
The Blue Butterfly Campaign was initiated by Max’s Blue Butterfly, a non-profit organization created to raise money for research to find a cure for childhood Acute Myeloid Leukemia (AML). Leukemia is tragically now the leading cause of death among children and is shockingly under-funded. The Blue Butterfly Campaign is designed to change that! Read more >>>
TO LEARN MORE CHECK OUT OUR VIDEO>>
Thanks to millions of dollars in funding and the work of many respected organizations, there is a 90% survival rate for the most common form of childhood leukemia, Acute Lymphocytic Leukemia (ALL). We are specifically targeting AML because it is a less common sub-type of childhood leukemia and also has the highest mortality rate for children (40-50% survival).
Pharmaceutical companies are typically the largest funders of research in any area, and often for business purposes they focus the majority of their efforts on diseases that impact the largest groups. Because AML cases represent a smaller percentage of all childhood leukemia diagnoses this disease is currently underfunded. According to most leading experts in this field “much work remains to be done to improve outcomes for this group of patients.” Our mission is to help eradicate childhood cancer.
2013 donation, $30,000 check presented to the Cincinnati Children's Hospital, where they are diligently doing research to find a cure of AML in children. We are honored to be connected to them!
Max’s Blue Butterfly is a 501 (c)(3) non-profit organization which is run strictly by volunteers. Our organization is solely funded by individual and community contributions. We do not receive any federal or state funding. All donations are tax-deductible.
Thanks t0 YOU!
Thanks to generous supporters like you, together we have raised over $175,000 so far! Learn more about the previous research the BBC supported>>
In 2014, Blue Butterfly Campaign will donate funds to Dr. Kurre’s Research at Doernbecher Children’s Hospital, which is focused on using simple blood draws for early non-invasive diagnosis of acute myeloid leukemia (AML).
Almost half of all children with AML continue to suffer relapses of the disease. Currently, detecting a relapse requires drilling into the hip for bone marrow sampling. With this practice, the relapsed leukemia is detected too late causing children to need intense chemotherapy, radiation and stem cell transplantation treatments. In other cases, the reoccurrence of leukemia goes undetected. This current approach of bone marrow aspiration is not only painful and invasive, but only successful in detecting the leukemia in one of every 40 procedures performed.
No instrument at OHSU is currently capable of detecting special markers released by leukemic cells in the blood. Blue Butterfly Campaign’s fundraising goal is to purchase the screening equipment that will allow Dr. Kurre and his team to begin the critical research that will move their studies closer to helping the kids with AML.
Click here to learn more about Dr. Kurre.
Make a Difference In Style